On February 25, 2019 Sorrento Therapeutics, Inc. (NASDAQ: SRNE, "Sorrento") reported that senior management will provide a corporate overview at the upcoming SVB/Leerink Global Healthcare Conference, and the Oppenheimer & Co. 29th Annual Healthcare Conference, both taking place in New York City (Press release, Sorrento Therapeutics, FEB 25, 2019, http://investors.sorrentotherapeutics.com/news-releases/news-release-details/sorrento-therapeutics-present-corporate-update-two-investor [SID1234533627]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

A copy of the presentation materials will be made available on the company website (www.sorrentotherapeutics.com).

SVB/LEERINK Global Healthcare Conference

Date: Thursday, February 28
Time: 3:30pm Eastern Time
Location: Lotte New York Palace Hotel
Webcast: View Source
Oppenheimer & Co. 29th Annual Healthcare Conference

Date: Wednesday, March 20
Time: 2:45pm Eastern Time
Location: Westin Grand Central Hotel, Ambassador Room
Webcast: View Source